As of June 2024 Adial Pharmaceuticals has a market cap of $6.13 Million. This makes Adial Pharmaceuticals the world's 8274th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $6.13 M | 170.95% |
2023 | $2.26 M | -60.76% |
2022 | $5.77 M | -89.79% |
2021 | $56.55 M | 131.14% |
2020 | $24.46 M | -1.6% |
2019 | $24.86 M | -28.97% |
2018 | $35 M |
On May 31st, 2024 the market cap of Adial Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $18.25 M | 197.36% | Bahamas |
NRC Health
NRC | $0.67 B | 10,822.81% | ๐บ๐ธ USA |